Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Telstar Provides Safety Cabinets to NUI Galway’s Biomedical Research Facility

Published: Wednesday, March 19, 2014
Last Updated: Wednesday, March 19, 2014
Bookmark and Share
The new, recently inaugurated research facility, which is directed towards cancer research, regenerative medicine and glycosciences, takes its place as one of five global hubs in the medtech sector.

A complete package comprising 63 cabinets developed by Telstar has been delivered to the new Biomedical Science Research Facility at the National University of Ireland in Galway (NUI Galway).

The activities of NUI Galway’s Biomedical Science Research Facility are specifically directed towards cancer research, regenerative medicine and glycosciences.

The cabinets provided by Telstar have been designed considering specific bioprocessing applications in the medical and clinical research field.

The suite of cabinets provided by Telstar represent a new generation of innovative biological safety cabinets designed to work in research environments such as tissue culture suites, radiochemistry, flow cytometry, screening core, sample preparation and biomimic areas.

The cabinets developed by Telstar for NUI Galway’s Biomedical Science Research Facility are more compact and optimize the usable work area in laboratories with limited space.

The cabinet design offers a body 20% smaller than the market average while maintaining standard work space.

Intended for the laminar flow manipulation of microorganisms with biological risk levels 2 and 3, the new range of Telstar safety cabinets offers an ergonomic design that adapts easily to small spaces, especially in laboratories with low ceilings and where several pieces of equipment need to be used in the same area.

Of the total of cabinets designed by Telstar, 57 of them correspond to Telstar Bio II Advance range, the class II cabinet designed in accordance EN12469 standard, and 6 units of EF B range of class II B2 cabinets in accordance with NSF49 standard.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Immunotherapy Agent Benefits Patients with Drug-Resistant Multiple Myeloma in First Human Trial
Daratumumab proved generally safe in patients, even at the highest doses.
Inciting an Immune Attack On Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
Less May Be More in Slowing Cholera Epidemics
Mathematical model shows more cases may be prevented and more lives saved when using one dose of cholera vaccine instead of recommended two doses.
NIH Launches Human RSV Study
Study aims to understand infection in healthy adults to aid development of RSV medicines, vaccines.
Flu Remedies Help Combat E. coli Bacteria
Physiologists from the University of Zurich have now discovered why the intestinal bacterium Escherichia coli (E. coli) multiplies heavily and has an inflammatory effect.
'Fountain of Youth' Protein Points to Possible Human Health Benefit
Patients with higher blood levels of growth factor have lower risk of cardiovascular problems.
Lemon Juice and Human Norovirus
Citric acid may prevent the highly contagious norovirus from infecting humans, scientists discovered from the German Cancer Research Center.
Study Backs Flu Vaccinations for Elderly
Brown University researchers found vaccines well matched to the year’s flu strain significantly reduce deaths and hospitalizations compared to when the match is poor, suggesting that vaccination indeed makes a difference.
Inciting an Immune Attack on Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
Protein Found to Play a Key Role in Blocking Pathogen Survival
Calprotectin fends off microbial invaders by limiting access to iron, an important nutrient.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!